BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26386809)

  • 1. Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: insights from spirometry and body plethysmography.
    Gotzmann M; Knoop H; Ewers A; Mügge A; Walther JW
    Am Heart J; 2015 Oct; 170(4):837-842.e1. PubMed ID: 26386809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.
    Gotzmann M; Czauderna A; Aweimer A; Hehnen T; Bösche L; Lind A; Kloppe A; Mügge A; Ewers A
    J Heart Valve Dis; 2014 Sep; 23(5):537-44. PubMed ID: 25799701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry.
    de Brito FS; Carvalho LA; Sarmento-Leite R; Mangione JA; Lemos P; Siciliano A; Caramori P; São Thiago L; Grube E; Abizaid A;
    Catheter Cardiovasc Interv; 2015 Apr; 85(5):E153-62. PubMed ID: 25510532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Lower-Surgical-Risk Patients With Chronic Obstructive Pulmonary Disease.
    Auffret V; Becerra Munoz V; Loirat A; Dumont E; Le Breton H; Paradis JM; Doyle D; De Larochellière R; Mohammadi S; Verhoye JP; Dagenais F; Bedossa M; Boulmier D; Leurent G; Asmarats L; Regueiro A; Chamandi C; Rodriguez-Gabella T; Voisine E; Moisan AS; Thoenes M; Côté M; Puri R; Voisine P; Rodés-Cabau J
    Am J Cardiol; 2017 Nov; 120(10):1863-1868. PubMed ID: 28886850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical characteristics and outcomes of high-risk patients treated for severe aortic stenosis prior to and after transcatheter aortic valve implantation availability.
    Attias D; Maillet JM; Copie X; Bonnet N; Mesnildrey P; Benvenuti C; Benacerraf M; Scheublé A; Digne F; Stratiev V; Guyon P
    Eur J Cardiothorac Surg; 2015 May; 47(5):e206-12. PubMed ID: 25687453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes for Patients With Severe Symptomatic Aortic Stenosis Treated With Transcatheter Aortic Valve Implantation.
    Codner P; Orvin K; Assali A; Sharony R; Vaknin-Assa H; Shapira Y; Schwartzenberg S; Bental T; Sagie A; Kornowski R
    Am J Cardiol; 2015 Nov; 116(9):1391-8. PubMed ID: 26342515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
    O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year outcomes for patients with severe symptomatic aortic stenosis treated with transcatheter aortic valve implantation.
    Codner P; Assali A; Dvir D; Vaknin-Assa H; Porat E; Shapira Y; Kupershmidt M; Bental T; Battler A; Sagie A; Kornowski R
    Am J Cardiol; 2013 May; 111(9):1330-6. PubMed ID: 23415022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry.
    Abdel-Wahab M; Zahn R; Gerckens U; Linke A; Sievert H; Schäfer U; Kahlert P; Hambrecht R; Sack S; Hoffmann E; Senges J; Schneider S; Richardt G;
    Heart; 2014 Aug; 100(16):1250-6. PubMed ID: 24895354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of patients with moderate and severe prosthetic aortic valve regurgitation after transcatheter aortic valve implantation.
    Gotzmann M; Korten M; Bojara W; Lindstaedt M; Rahlmann P; Mügge A; Ewers A
    Am J Cardiol; 2012 Nov; 110(10):1500-6. PubMed ID: 22863177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death.
    Houthuizen P; Van Garsse LA; Poels TT; de Jaegere P; van der Boon RM; Swinkels BM; Ten Berg JM; van der Kley F; Schalij MJ; Baan J; Cocchieri R; Brueren GR; van Straten AH; den Heijer P; Bentala M; van Ommen V; Kluin J; Stella PR; Prins MH; Maessen JG; Prinzen FW
    Circulation; 2012 Aug; 126(6):720-8. PubMed ID: 22791865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort.
    Schymik G; Tzamalis P; Bramlage P; Heimeshoff M; Würth A; Wondraschek R; Gonska BD; Posival H; Schmitt C; Schröfel H; Luik A
    Clin Res Cardiol; 2015 Apr; 104(4):351-62. PubMed ID: 25388650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing characteristics and outcomes of patients undergoing surgical aortic valve replacement in the transcatheter aortic valve implantation era.
    Rozen G; Fefer P; Shinfeld A; Sternik L; Guetta V; Malachy A; Levin S; Feinberg M; Raanani E; Segev A
    J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):261-6. PubMed ID: 25004001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results.
    Muñoz-García AJ; del Valle R; Trillo-Nouche R; Elízaga J; Gimeno F; Hernández-Antolín R; Teles R; de Gama Ribeiro V; Molina E; Cequier A; Urbano-Carrillo C; Cruz-González I; Payaslian M; Patricio L; Sztejfman M; Iñiguez A; Rodríguez V; Scuteri A; Caorsi C; López-Otero D; Avanzas P; Alonso-Briales JH; Hernández-García JM; Morís C;
    Int J Cardiol; 2013 Nov; 169(5):359-65. PubMed ID: 24128731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response.
    Gotzmann M; Pljakic A; Bojara W; Lindstaedt M; Ewers A; Germing A; Mügge A
    Am Heart J; 2011 Aug; 162(2):238-245.e1. PubMed ID: 21835283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement.
    Saia F; Latib A; Ciuca C; Gasparetto V; Napodano M; Sticchi A; Anderlucci L; Marrozzini C; Naganuma T; Alfieri O; Facchin M; Hoxha B; Moretti C; Marzocchi A; Colombo A; Tarantini G
    Am Heart J; 2014 Nov; 168(5):798-806. PubMed ID: 25440810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
    Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
    J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.